ProSpec

Production of Recombinant Proteins, Cytokines, Growth Factors, and Chemokines

Retail Platforms
Private
Follow

Company Overview

Snapshot

Founded in January 2000, ProSpec operates with 1–10 employees. The company specializes in the production and purification of recombinant proteins and related products for the research community. In August 2016, ProSpec's products and applications were highlighted by Bionovus Life Sciences, underscoring their relevance in the biotechnology sector.

Business overview

ProSpec is a biotechnology company that provides highly purified proteins globally. The company's core technology focuses on the production and purification of recombinant cytokines and chemokines from bacterial systems, catering to the needs of the research community. Its main product lines support research in areas such as cancer, apoptosis, development, endocrinology, immunology, neuroscience, proteases, and stem cells. ProSpec operates within the Pharmaceuticals sector, serving the broader Health Tech & Life Sciences industry.

Strategic signal

In August 2016, ProSpec's product portfolio and applications were featured by Bionovus Life Sciences, indicating the company's established presence and utility within the biotechnology research community. This highlights ProSpec's ongoing contribution of specialized recombinant proteins, which are critical reagents for various scientific studies, signaling continued relevance and demand for its offerings in the life sciences market.

Log in to access full profile

Company Intelligence Q&A

What is ProSpec's primary focus?
ProSpec specializes in the production and purification of recombinant cytokines and chemokines from bacterial systems, providing highly purified proteins worldwide for the research community.
When was ProSpec founded?
ProSpec was founded in January 2000.
What types of products does ProSpec offer?
ProSpec offers a range of cytokine-related products for research in cancer, apoptosis, development, endocrinology, immunology, neuroscience, proteases, and stem cells, including interferons, interleukins, bone morphogenic proteins, tumor necrosis factors, leptins, and stem cell factors.
Which markets does ProSpec serve?
ProSpec serves geomarkets including the United States, Canada, the United Kingdom, Germany, France, Italy, Sweden, Finland, the Netherlands, Switzerland, Israel, Japan, South Korea, Hong Kong, Australia, and New Zealand.
Log in to access full profile